Skip to Content

Extina Approval History

  • FDA approved: Yes (First approved June 12th, 2007)
  • Brand name: Extina
  • Generic name: ketoconazole
  • Dosage form: Foam
  • Company: Stiefel Laboratories, Inc.
  • Treatment for: Seborrheic Dermatitis

Extina Foam is a topical formulation of the antifungal ketoconazole in VersaFoam for the treatment of seborrheic dermatitis.

Development History and FDA Approval Process for Extina

Jun 13, 2007Approval FDA Approves Extina for the Treatment of Seborrheic Dermatitis
Nov 24, 2004Connetics Receives FDA Non-Approvable Letter for Extina
Apr  8, 2004Connetics' New Drug Application for Extina Has Been Accepted for Filing by the FDA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.